Cytek Biosciences Inc (CTKB) - Company Sales

Cytek Biosciences, Inc. (CTKB) is implementing energy-efficient electronics and reducing reagent consumption in its analyzers. The company's sales timeline visualizes commercial rhythm, where 0.21 represents the current metric level. Strong spectrometer patents and strict FDA oversight create a defensive barrier, while the launch of automated cytometry software stimulates further business growth.

CTKB Cytek Biosciences Inc: Company Sales in the range 07/04/2022 - 11/13/2026

Analytical breakdowns for Cytek Biosciences, Inc.

- market value and analyst target forecast:

Market Chart Cytek Corp|CTKB - Analyst Consensus Forecast

- market capitalization indicators:

Market Valuation Cytek Biosciences, Inc.|CTKB - Real Price to Acquire Entire Company

- balance sheet equity data:

Net Asset Value per Share Cytek Biosciences|CTKB - Company Net Assets|Market Cap to Book Value Multiple cytekbio.com|CTKB - Company Total Assets

- debt obligations and liquidity statistics:

- business earnings and investment ratios data:

CTKB - Company Net Income|Expected Net Profit Cytek Biosciences, Inc.|CTKB - Price to Earnings Ratio|Market Cap to Projected Earnings cytekbio.com|CTKB - PEG Multiple|Enterprise Value to EBITDA Ratio Cytek Biosciences, Inc.|CTKB - Operating profit EBITDA|Net earnings per share for the last four quarters Cytek Biosciences|CTKB - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months cytekbio.com|CTKB - Earnings per share growth in current year|Projected earnings per share growth rate for next year Cytek Biosciences, Inc.

- issuer revenue and sales details:

CTKB - Revenue and Sales Volume|Company Future Sales Volume Cytek Corp|CTKB - P/S Multiple|Market Cap to Future Revenue Ratio Cytek Biosciences, Inc.

General company analysis:Cytek Corp - CTKB

The growth of Cytek Biosciences, Inc. (CTKB) depends directly on the scaling of the Aurora ecosystem and the consumption of high-cost reagents. The company's current sales volume on the GURU.Markets platform illustrates the daily revenue dynamics from the sale of these products. This indicator assesses the resilience of cash flow to market volatility and technological pressure. Analysis of the curve allows for the identification of demand anomalies, signaling risks of the asset being overbought. The stability of this metric confirms the fundamental value of the capital.

Key competitors